Although these drugs have been widely used in the clinical control of diabetes, the use of glP-1 receptor-associated drugs in some populations has been associated with severe gastrointestinal reactions (nausea, diarrhea, and vomiting) and even anorexia (11–13). This evidence concerns the gene GLP1R and diabetes mellitus.